StreetAlpha.app
Home › Stocks › AYTU

Aytu Biopharma, Inc (AYTU)

Members
LATEST PRICE

Aytu BioPharma sells prescription medicines for depression, ADHD and allergic conditions from its base in Denver, Colorado. AYTU reports earnings on Thu, Nov 12, 2026.

Prices, price targets and earnings estimates for AYTU are shown to AI Starter and AI Pro members. Ratings, flow and news are open to everyone.See plans
AI Auto Pilots
Is AYTU in one of our four AI portfolios? Sign in free to see
See how it works→ Details ↓

Earnings

Earnings calendar →
Next report
Nov 12
2026 · Time not announced
Consensus EPS forecast
Members
EPS and revenue estimates
Year-ago EPS
Members
Same quarter last year
Options-implied move
Members
Move priced in by options
Analyst consensus
1 Buy
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy
1firm
1 Buy0 Hold0 Sell
Only 1 firm rated AYTU in the past 90 days, not enough for a consensus
Average 12-month target
Price targets for AYTUThe average, highest and lowest analyst targets and the target chart are shown to AI Starter and AI Pro members.See plans
Latest rating changes
Ascendiant CapitalTarget raised
Sep 30Buy
Ascendiant CapitalMaintained
Jun 11Buy
DateFirmActionRatingPrice target
Sep 30Ascendiant CapitalTarget raisedBuy
Jun 11Ascendiant CapitalMaintainedBuy
Loading…

Whale Options Flow

90D

No whale options trades in AYTU in the last 90 days.

Loading…

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AYTU is in one of them and how their past AYTU trades turned out.

See how it works→ View all auto pilots→
AYTU in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered AYTU in an article yet. Here's the latest on the wider market.

macronewsFriday, October 30, 2026
Binance and Polymarket Hacks Test Crypto's Plumbing, Not Yet Macro
Binance paused withdrawals after a suspected theft of roughly $6 billion, while Polymarket halted trading for an hour after a vendor breach.
Jean Westart · 3 min read
macronewsMonday, October 26, 2026
S&P 500 Sits 2.5% Below Its Record Ahead of the Fed and Big Tech
The S&P 500 slipped 0.47% to 7,623.68, 2.5% below its record, as the Fed meets October 28 and Alphabet, Microsoft and Amazon report.
Marie Crown · 3 min read
macronewsMonday, October 26, 2026
Hightower's Stephanie Link Tells Investors to Add on Volatility
Hightower's Stephanie Link told CNBC's Squawk Box that investors should use market volatility to add to portfolios as earnings season unfolds.
Adam Landser · 2 min read

About Aytu Biopharma

Aytu BioPharma is a pharmaceutical company based in Denver, Colorado, that markets and sells prescription medicines for central nervous system conditions. Its main product is EXXUA, a treatment for major depressive disorder in adults. The company also sells ADHD medicines, Adzenys and Cotempla, and Karbinal, an antihistamine suspension used to treat allergic conditions. It sells its products mainly through wholesalers and pharmacies.

Headquarters
Denver, CO
Summary based on the company’s 2026 annual report (10-K) ↗